<?xml version="1.0" encoding="UTF-8"?>
<study xmlns="gme://ccts.cabig/1.0/gov.nih.nci.cabig.ccts.domain" gridId="a1817d28-6227-4cf8-a37e-8e04dd12bdb0" version="23"><blindedIndicator>false</blindedIndicator><multiInstitutionIndicator>true</multiInstitutionIndicator><randomizedIndicator>true</randomizedIndicator><shortTitleText>ECOG Study</shortTitleText><longTitleText>Phase III Trial of Bevacizumab (NSC 704865), Oxaliplatin (NSC 266046), Fluorouracil and Leucovorin Versus Oxaliplatin, Fluorouracil and&#xd;
Leucovorin Versus Bevacizumab</longTitleText><descriptionText></descriptionText><precisText></precisText><phaseCode>Phase III Trial</phaseCode><consentVersion>01/01/2000</consentVersion><dataEntryStatus>COMPLETE</dataEntryStatus><coordinatingCenterStudyStatus>ACTIVE</coordinatingCenterStudyStatus><type>Primary Treatment</type><targetAccrualNumber>880</targetAccrualNumber><organizationAssignedIdentifier><type>Coordinating Center Identifier</type><value>ECOG-201</value><primaryIndicator>true</primaryIndicator><healthcareSite><name>Eastern Cooperative Oncology Group</name><address><streetAddress>900 Commonwealth Avenue</streetAddress><city>Boston</city><stateCode>MA</stateCode><postalCode>02215</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>ECOG</nciInstituteCode></healthcareSite></organizationAssignedIdentifier><organizationAssignedIdentifier><type>Protocol Authority Identifier</type><value>ECOG-876</value><primaryIndicator>false</primaryIndicator><healthcareSite><name>Eastern Cooperative Oncology Group</name><address><streetAddress>900 Commonwealth Avenue</streetAddress><city>Boston</city><stateCode>MA</stateCode><postalCode>02215</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>ECOG</nciInstituteCode></healthcareSite></organizationAssignedIdentifier><nonTreatmentEpoch gridId="3773edd6-2fa4-42d6-86e6-abd8331137f0"><name>Screening Epoch</name><descriptionText></descriptionText><accrualCeiling>30</accrualCeiling><accrualIndicator>true</accrualIndicator><reservationIndicator>false</reservationIndicator><enrollmentIndicator>false</enrollmentIndicator></nonTreatmentEpoch><treatmentEpoch gridId="960436a6-6b78-4210-8962-2dfd14bbb26e"><name>Treatment Epoch</name><descriptionText></descriptionText><arm gridId="8c295df9-38c0-4692-b274-6399b34556f5"><name>Arm A</name><descriptionText></descriptionText><targetAccrualNumber>300</targetAccrualNumber></arm><arm gridId="6021b9b3-b3e0-4cc7-a999-4d8c97799e43"><name>Arm B</name><descriptionText></descriptionText><targetAccrualNumber>290</targetAccrualNumber></arm><arm gridId="cc8b3b9f-7821-4f5b-85ea-dd7ee8f44507"><name>Arm C</name><descriptionText></descriptionText><targetAccrualNumber>290</targetAccrualNumber></arm><exclusionCriteria gridId="c982afdb-9781-46ae-bc36-f57455328aa0"><notApplicableIndicator>false</notApplicableIndicator><questionNumber>0</questionNumber><questionText>Has the patient been treated with prior radiation?</questionText></exclusionCriteria><exclusionCriteria gridId="935d5498-6ec7-45bf-95fb-874faae8e56a"><notApplicableIndicator>true</notApplicableIndicator><questionNumber>0</questionNumber><questionText>Is the patient pregnant?</questionText></exclusionCriteria><inclusionCriteria gridId="87c4c71d-5a1c-4daa-bdd5-5288433a6461"><notApplicableIndicator>false</notApplicableIndicator><questionNumber>0</questionNumber><questionText>Is WBC &gt;= 1500</questionText></inclusionCriteria><inclusionCriteria gridId="0017ca02-f155-46c3-9e57-7441809d2ef9"><notApplicableIndicator>false</notApplicableIndicator><questionNumber>0</questionNumber><questionText>Is SGOT &gt; 12</questionText></inclusionCriteria><stratificationCriteria><questionText>What is the patient's age?</questionText><permissibleAnswer><permissibleAnswer>&lt; 18</permissibleAnswer></permissibleAnswer><permissibleAnswer><permissibleAnswer>&gt;= 18, &lt; 65</permissibleAnswer></permissibleAnswer><permissibleAnswer><permissibleAnswer>&gt;= 65</permissibleAnswer></permissibleAnswer></stratificationCriteria><stratificationCriteria><questionText>What is the patient's sex?</questionText><permissibleAnswer><permissibleAnswer>Male</permissibleAnswer></permissibleAnswer><permissibleAnswer><permissibleAnswer>Female</permissibleAnswer></permissibleAnswer></stratificationCriteria></treatmentEpoch><studyCoordinatingCenter gridId="d36a8f4e-473b-49de-b2d6-de47b3f57e4e"><healthcareSite><name>Eastern Cooperative Oncology Group</name><address><streetAddress>900 Commonwealth Avenue</streetAddress><city>Boston</city><stateCode>MA</stateCode><postalCode>02215</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>ECOG</nciInstituteCode></healthcareSite><studyInvestigator><roleCode>Principal Investigator</roleCode><statusCode>Active</statusCode><healthcareSiteInvestigator><investigator><nciIdentifier>NCI-8270</nciIdentifier><fullName>Bruce J Giantonio</fullName></investigator></healthcareSiteInvestigator></studyInvestigator><studyInvestigator><roleCode>Site Investigator</roleCode><statusCode>Active</statusCode><healthcareSiteInvestigator><investigator><nciIdentifier>NCI-2986</nciIdentifier><fullName>Neal Jay Meropol</fullName></investigator></healthcareSiteInvestigator></studyInvestigator></studyCoordinatingCenter><studyFundingSponsor gridId="680d8275-eafd-4423-a58d-47220ef576f2"><healthcareSite><name>Eastern Cooperative Oncology Group</name><address><streetAddress>900 Commonwealth Avenue</streetAddress><city>Boston</city><stateCode>MA</stateCode><postalCode>02215</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>ECOG</nciInstituteCode></healthcareSite></studyFundingSponsor><studySite gridId="3815f331-4f73-428f-abdf-7254065b7df6"><healthcareSite><name>Eastern Cooperative Oncology Group</name><address><streetAddress>900 Commonwealth Avenue</streetAddress><city>Boston</city><stateCode>MA</stateCode><postalCode>02215</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>ECOG</nciInstituteCode></healthcareSite><irbApprovalDate>2008-04-12</irbApprovalDate><roleCode>Affiliate Site</roleCode><startDate>2000-01-10</startDate><siteStudyStatus>ACTIVE</siteStudyStatus></studySite><studySite gridId="6b6d05f2-5191-410a-8432-deb84040ec68"><healthcareSite><name>Cancer and Leukemia Group B</name><address><streetAddress>230 West Monroe</streetAddress><city>Chicago</city><stateCode>IL</stateCode><postalCode>60606</postalCode><countryCode>USA</countryCode></address><nciInstituteCode>CALGB</nciInstituteCode></healthcareSite><irbApprovalDate>2008-03-19</irbApprovalDate><roleCode>Affiliate Site</roleCode><startDate>2000-01-21</startDate><siteStudyStatus>ACTIVE</siteStudyStatus></studySite><studySite gridId="23566f0e-72ef-42af-ad60-7d4fbcc5d5d8"><healthcareSite><name>Duke University Medical Center</name><address><city>Durham</city><stateCode>NC</stateCode><countryCode>USA</countryCode></address><nciInstituteCode>NC010</nciInstituteCode></healthcareSite><studyInvestigator><roleCode>Site Investigator</roleCode><statusCode>Active</statusCode><healthcareSiteInvestigator><investigator><nciIdentifier>NCI2093823</nciIdentifier><fullName>Pankaj Agarwal</fullName></investigator></healthcareSiteInvestigator></studyInvestigator><studyInvestigator><roleCode>Site Investigator</roleCode><statusCode>Active</statusCode><healthcareSiteInvestigator><investigator><nciIdentifier>NCI918133</nciIdentifier><fullName>Peter James</fullName></investigator></healthcareSiteInvestigator></studyInvestigator><irbApprovalDate>2008-02-05</irbApprovalDate><roleCode>Affiliate Site</roleCode><startDate>2000-01-28</startDate><siteStudyStatus>ACTIVE</siteStudyStatus></studySite></study>